Mantle Cell Lymphoma Management in North Carolina: Updates for 2020 SPOC
Dr. Christopher Dittus from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for rare lymphomas for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
- Explain the diagnosis of mantle cell lymphoma.
- Describe high risk mantle cell lymphoma.
- Describe the frontline treatment approach for mantle cell lymphoma.
- Describe new modalities for treating relapsed mantle cell lymphoma.
Christopher Dittus, DO, MPH
Presenter Disclosure Information
Christopher Dittus, DO, MPH, has no relevant financial relationships with commercial interests as defined by the ACCME.
This Non-Credit Course does not have accreditation. It only offers general participation certificates.
- 1.00 Participation
UNC Lineberger Cancer Network certificate of participation.
Tim Poe, Director of Telehealth